Antigen Affinity Purified Polyclonal Antibodies

Anti-Human MIP-1α (CCL3) (Polyclonal Rabbit)

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 500-P38

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits pre-immunized with highly pure recombinant Human MIP-1α. Anti-Human MIP-1α specific antibody was purified by affinity chromatography employing immobilized Human MIP-1α matrix.

Immunogen: E.coli derived Recombinant Human MIP-1α (CCL3) (PeproTech catalog# 300-08)

Sandwich ELISA: To detect Human MIP-1α by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human MIP-1α (500-P38Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human MIP-1α.

Anti-Human MIP-1α (CCL3) Sandwich ELISA

Western Blot: To detect Human MIP-1α by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/ml. When used in conjunction with compatible secondary reagents the detection limit for recombinant Human MIP-1α is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human MIP-1α (CCL3) Western Blot Reduced Anti-Human MIP-1α (CCL3) Western Blot Unreduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

First Author
Rius, C
Title
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.
Citation
Journal of immunology (Baltimore, Md. : 1950); 185(6) pg3718-27
PubMed Id
First Author
Izhak, L
Title
Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner.
Citation
Journal of immunology (Baltimore, Md. : 1950); 184(2) pg1092-101
PubMed Id
First Author
Pilette, C
Title
CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge.
Citation
The European Respiratory Journal; 23(6) pg876-84
PubMed Id